Abstract:
Systems and methods of identifying and processing complex text are provided. If a presentation data stream contains a complex text string, a preselected control in the presentation data stream is inserted before the complex text string. A first parameter has a value indicating a control type for controlling processing of complex text, and a second parameter takes one or more values for enabling and disabling the processing of complex text. In processing complex text, responsive to a first predetermined type of control in a presentation data stream, if the first type of complex text processing is enabled, this processing is applied to a complex text string succeeding the first predetermined type of control in the presentation data stream. The first predetermined type of control includes a first parameter represented by a corresponding value for controlling the first type of complex text processing.
Abstract:
The invention relates to network communications. A first protocol that encapsulates a plurality of secondary protocols is used to communicate over a network. Use of the first protocol provides session persistence and a reliable connection between a client and a host service. In one embodiment of this aspect of the inventions,, a second connection is established between the first protocol service and a host service using one of the secondary protocols. Communication between the first protocol service and the host service occurs via one of the secondary protocols. In another embodiment, a plurality of second connections are established between the first protocol service and a plurality of host services using the plurality of the secondary protocols. Specifically, each of the plurality of second connections is established between the first protocol service and a different host service and each of the plurality of second connections is established using one of the plurality of secondary protocols. Communication between the first protocol service and the plurality of host services occurs over each of the plurality of second connections via one of the plurality of secondary protocols. In yet another embodiment, the first connection between the client and the first protocol service is established through an intermadiary node. The first protocol can be communicated over TCP/IP and the secondary protocol can be, for example, HTTP, RDP, ICA, FTP, Oscar or Telnet. Additionally, each virtual channel can include a plurality of protocol packets that enable remote access functionality.
Abstract:
The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
A tap sub-assembly comprises a cover member (19) and a handle (18) rotatably attached thereto. The handle is adapted for connection with a tap operating spindle (17) extending outwardly from an architectural surface (13). The cover member is apertured for the passage therethrough of the spindle and is formed for attachment to the surface.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
Disclosed are polypeptides and nucleic acids encoding same. Also disclosed are vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same.
Abstract:
Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
Abstract:
The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment ofa broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases.